Skip to main content
Equibles

DIMENSIONAL FUND ADVISORS LP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 354204 AUSTIN, TX
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$408,833
-$872,638 QoQ
Shares Held
358,627
-61.1% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 170 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 26% Shared 25% None 49%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. AKBA ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 25,417,271 $625,519,037
2 VTRS
Viatris Inc
 29,970,094 $475,925,092
3 UTHR
UNITED THERAPEUTICS Corp
 527,904 $286,034,221
4 ALKS
Alkermes plc.
 4,194,873 $219,811,343
5 LNTH
Lantheus Holdings, Inc.
 1,466,260 $162,666,882
6 ZTS
Zoetis Inc.
 2,173,278 $156,171,754
7 PBH
Prestige Consumer Healthcare Inc.
 2,661,291 $125,799,224
8 NBIX
Neurocrine Biosciences Inc
 732,877 $123,519,088

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $408,833 358,627
2026-03-31 $1,281,471 921,923
2025-12-31 $2,529,328 1,571,012
2025-09-30 $4,823,066 1,766,691
2025-06-30 $3,210,846 882,101
2025-03-31 $1,028,026 535,431
2024-12-31 $238,791 125,680
2022-09-30 $198,304 627,549
2022-06-30 $276,282 782,675
2022-03-31 $1,914,806 2,666,861
2021-12-31 $5,862,080 2,593,841
2021-09-30 $6,035,797 2,095,763
2021-06-30 $12,905,408 3,405,121
2021-03-31 $8,233,196 2,432,259
2020-12-31 $4,892,451 1,747,304
2020-09-30 $4,411,917 1,757,736
2020-06-30 $25,798,211 1,899,721
2020-03-31 $13,980,726 1,844,423